Leidos Holdings, Inc. - LDOS STOCK NEWS

The Leidos Partnership for Defense Health has announced further deployments of the MHS GENESIS electronic health record system at military treatment facilities in Nevada, California, and Alaska. This initiative, which started in 2015, aims to streamline health records for millions of service members and their families. Up to 10,000 clinicians can now access a unified health record. Recent waves have included significant expansions for the U.S. Coast Guard, with full deployment expected by the end of 2023.

Leidos Holdings reported third-quarter revenues of $3.24 billion, a 14.4% increase from the previous year, attributed to acquisitions of Dynetics and L3Harris Technologies' SD&A Businesses. Operating income rose to $258 million with a margin decrease to 8.0%. Diluted EPS reached $1.13, slightly up from $1.11. The company revised fiscal 2020 guidance, projecting revenues between $12.3 billion and $12.5 billion and non-GAAP diluted EPS of $5.65 to $5.85. Backlog stands at $31.7 billion.

Leidos Holdings, Inc. (NYSE: LDOS) has declared a quarterly cash dividend of $0.34 per share, payable on Dec. 31, 2020, to stockholders of record as of Dec. 15, 2020. The announcement reflects the company's ongoing commitment to returning value to its shareholders. For the fiscal year ended January 3, 2020, Leidos reported annual revenues of approximately $11.09 billion.

Leidos (NYSE:LDOS) announced on October 29, 2020, a contract award from the Office of the Under Secretary of Defense for Personnel and Readiness worth approximately $75 million. The contract includes a one-year base period and four additional one-year options, primarily based in San Antonio, Texas. Leidos will support the Defense Civilian Human Resource Management System (DCHRMS), integrating six databases to enhance efficiency and reduce costs for DoD HR professionals and civilian employees.

Leidos (NYSE:LDOS) has secured a follow-on contract valued at $306 million from Army Contracting Command to provide comprehensive operations for the Saturn Arch aircraft. This contract features a one-year base period with two additional one-year options and a six-month extension, taking place at Bridgewater Airport, Virginia, and various OCONUS sites. Leidos aims to leverage its expertise in aerial intelligence systems for engineering and technical enhancements. Annual revenues reported for FY 2020 were approximately $11.09 billion.

On October 5, 2020, Leidos (NYSE: LDOS) announced the pricing of $1 billion in senior unsecured notes, with a 2.300% interest rate due in 2031. These notes will be fully guaranteed by Leidos and are intended for qualified institutional buyers. Proceeds will be used for general corporate purposes, including debt repayment. The offering is expected to close on October 8, 2020, subject to standard conditions. This issuance strengthens Leidos' financial position while allowing it to manage its loan facilities more effectively.

Leidos Holdings, Inc. (NYSE: LDOS) plans to initiate a private offering of senior unsecured notes under Rule 144A and Regulation S. The Issuer, Leidos, Inc., will use proceeds primarily for general corporate purposes, including repaying existing loans. The notes will be guaranteed by Leidos and subordinate to existing subsidiary liabilities. This offering targets qualified institutional buyers in the U.S. and non-U.S. persons abroad, without registration under the Securities Act. As of January 3, 2020, Leidos reported annual revenues of approximately $11.09 billion.

Leidos (NYSE: LDOS) has announced a conference call for November 2, 2020, at 8 a.m. ET to discuss its third quarter financial results ending October 2, 2020. The earnings announcement will precede the call on the same day. Interested parties can listen online at ir.leidos.com or via telephone at 877-869-3847 for U.S. callers and +1-201-689-8261 for international callers. A replay will be available from 11:30 a.m. ET on November 2 until November 9, 2020.